Evidence map›Paper›PMID 32149127›Full record

ArticleBioMed research international2020

Prognostic Factors Analysis and Nomogram Construction of Dual Primary Lung Cancer: A Population Study.

Cong-Kuan Song, Zi-Xin Guo, Xiao-Yan Shen, Yu-Jin Wang, Qing-Wen Wang, Dong-Hu Yu, Chen Chen, Xiao-Ping Liu, Jing-Yu Huang, Sheng Li and 1 more

Abstract read
In one paragraph

Article in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Cong-Kuan SongDepartment of Thoracic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Zi-Xin GuoDepartment of Thoracic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Xiao-Yan ShenDepartment of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan 430071, China.
Yu-Jin WangDepartment of Thoracic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Qing-Wen WangDepartment of Thoracic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Dong-Hu YuDepartment of Thoracic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Chen ChenDepartment of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Xiao-Ping LiuDepartment of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Jing-Yu HuangDepartment of Thoracic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Sheng LiDepartment of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.ORCID https://orcid.org/0000-0003-4070-7345
Weidong HuDepartment of Thoracic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.ORCID https://orcid.org/0000-0003-3646-8572

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a special type of lung cancer, multiple primary lung cancer (MPLC) has unique biological characteristics, and its research remains limited. The aim of our research was to identify prognostic factors and construct a prognostic nomogram of dual primary lung cancer (DPLC). A population cohort study of patients with DPLC was conducted using the extracted data from the Surveillance, Epidemiology, and End Results (SEER) database. Relevant survival variables were identified using the Cox proportional hazard model. Prognostic nomogram was performed and its predictive performance was validated via the modeling and validating cohort data. Additionally, propensity score matching (PSM) was also applied to evaluate whether surgery affected the OS of this study population. 5411 eligible DPLC patients were included in this study cohort, with 41.0% of 3-year OS rate and 27.7% of 5-year OS rate. Age, sex, race, grade, stage, lymph node (LN) metastasis, histological type, primary site, and surgery were considered to be prognostic factors of OS. The C-indexes of the established nomogram were 0.70 (95% CI (0.69, 0.71)) in the modeling group and 0.70 (95% CI (0.68, 0.72)) in the validation group, which showed an ideal model discrimination ability. AUC and calibration plots of 3- and 5-year OS also proved the good performance of the established nomogram. After 1 : 1 PSM, surgery can potentially reduce the risk of OS (HR = 0.63, 95% CI: 0.56-0.72) of DPLC. The prognostic nomogram with reliable performance was developed to predict 3- and 5-year OS rates, which could assist clinicians to make more reasonable survival prediction for DPLC patients. For patients without absolute surgical contraindications, surgery should be actively considered.

Indexed as

Lung NeoplasmsNomogramsPrognosisAdultAgedAged, 80 and overAge FactorsCohort StudiesFemaleHumansKaplan-Meier EstimateLymphatic MetastasisMaleMiddle AgedPropensity ScoreProportional Hazards Models

Identifiers

PMID32149127
PMCPMC7049836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.